80 related articles for article (PubMed ID: 15725384)
21. Characterization of a highly pathogenic molecular clone of feline immunodeficiency virus clade C.
de Rozières S; Mathiason CK; Rolston MR; Chatterji U; Hoover EA; Elder JH
J Virol; 2004 Sep; 78(17):8971-82. PubMed ID: 15308694
[TBL] [Abstract][Full Text] [Related]
22. The feline immunodeficiency virus vif gene is required for productive infection of feline peripheral blood mononuclear cells and monocyte-derived macrophages.
Lockridge KM; Himathongkham S; Sawai ET; Chienand M; Sparger EE
Virology; 1999 Aug; 261(1):25-30. PubMed ID: 10441553
[TBL] [Abstract][Full Text] [Related]
23. Sequences within the feline immunodeficiency virus long terminal repeat that regulate gene expression and respond to activation by feline herpesvirus type 1.
Kawaguchi Y; Norimine J; Miyazawa T; Kai C; Mikami T
Virology; 1992 Sep; 190(1):465-8. PubMed ID: 1326814
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the vif gene of feline immunodeficiency virus.
Shacklett BL; Luciw PA
Virology; 1994 Nov; 204(2):860-7. PubMed ID: 7941360
[TBL] [Abstract][Full Text] [Related]
25. Both the 5' and 3' LTRs of FIV contain minor RNA encapsidation determinants compared to the two core packaging determinants within the 5' untranslated region and gag.
Ghazawi A; Mustafa F; Phillip PS; Jayanth P; Ali J; Rizvi TA
Microbes Infect; 2006 Mar; 8(3):767-78. PubMed ID: 16513389
[TBL] [Abstract][Full Text] [Related]
26. CD8+ T cells from feline immunodeficiency virus (FIV) infected cats suppress exogenous FIV replication of their peripheral blood mononuclear cells in vitro.
Hohdatsu T; Sasagawa T; Yamazaki A; Motokawa K; Kusuhara H; Kaneshima T; Koyama H
Arch Virol; 2002 Aug; 147(8):1517-29. PubMed ID: 12181672
[TBL] [Abstract][Full Text] [Related]
27. Feline immunodeficiency virus can infect a human cell line (MOLT-4) but establishes a state of latency in the cells.
Ikeda Y; Tomonaga K; Kawaguchi Y; Kohmoto M; Inoshima Y; Tohya Y; Miyazawa T; Kai C; Mikami T
J Gen Virol; 1996 Aug; 77 ( Pt 8)():1623-30. PubMed ID: 8760408
[TBL] [Abstract][Full Text] [Related]
28. The effects of treatment with chemical agents or infection with feline viruses on protein-binding properties of the feline immunodeficiency virus long terminal repeat.
Ikeda Y; Kawaguchi Y; Inoshima Y; Kohmoto M; Shimojima M; Inada G; Sato E; Kai C; Miyazawa T; Mikami T
Virus Res; 1997 Oct; 51(2):203-12. PubMed ID: 9498618
[TBL] [Abstract][Full Text] [Related]
29. Replication rate of feline immunodeficiency virus in astrocytes is envelope dependent: implications for glutamate uptake.
Billaud JN; Selway D; Yu N; Phillips TR
Virology; 2000 Jan; 266(1):180-8. PubMed ID: 10612672
[TBL] [Abstract][Full Text] [Related]
30. Expression of feline immunodeficiency virus Vif is associated with reduced viral mutation rates without restoration of replication of vif mutant viruses.
Paul TA; Casey JW; Avery RJ; Sutton CA
Virology; 2007 Apr; 361(1):112-22. PubMed ID: 17169394
[TBL] [Abstract][Full Text] [Related]
31. Influence of ORF2 on host cell tropism of feline immunodeficiency virus.
Waters AK; De Parseval AP; Lerner DL; Neil JC; Thompson FJ; Elder JH
Virology; 1996 Jan; 215(1):10-6. PubMed ID: 8553580
[TBL] [Abstract][Full Text] [Related]
32. Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors.
Curran MA; Kaiser SM; Achacoso PL; Nolan GP
Mol Ther; 2000 Jan; 1(1):31-8. PubMed ID: 10933909
[TBL] [Abstract][Full Text] [Related]
33. [Feline immunodeficiency virus].
Martinon O; Lévy D
Vet Res; 1993; 24(2):151-8. PubMed ID: 8393723
[TBL] [Abstract][Full Text] [Related]
34. Viral transcriptome analysis of feline immunodeficiency virus infected cells using second generation sequencing technology.
Ertl R; Birzele F; Hildebrandt T; Klein D
Vet Immunol Immunopathol; 2011 Oct; 143(3-4):314-24. PubMed ID: 21742384
[TBL] [Abstract][Full Text] [Related]
35. Regulation of gene expression directed by the long terminal repeats of feline leukemia viruses.
Nishigaki K; Endo Y; Matsumoto Y; Watari T; Goitsuka R; Tsujimoto H; Hasegata A
Leukemia; 1997 Apr; 11 Suppl 3():189-92. PubMed ID: 9209339
[TBL] [Abstract][Full Text] [Related]
36. Functional domains in the feline immunodeficiency virus nucleocapsid protein.
Manrique ML; Rauddi ML; González SA; Affranchino JL
Virology; 2004 Sep; 327(1):83-92. PubMed ID: 15327900
[TBL] [Abstract][Full Text] [Related]
37. Construction and in vitro characterization of attenuated feline immunodeficiency virus long terminal repeat mutant viruses.
Bigornia L; Lockridge KM; Sparger EE
J Virol; 2001 Jan; 75(2):1054-60. PubMed ID: 11134320
[TBL] [Abstract][Full Text] [Related]
38. Feline CD8+ T cell non-cytolytic anti-feline immunodeficiency virus activity mediated by a soluble factor(s).
Hohdatsu T; Okubo M; Koyama H
J Gen Virol; 1998 Nov; 79 ( Pt 11)():2729-35. PubMed ID: 9820148
[TBL] [Abstract][Full Text] [Related]
39. Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-gamma.
Tanabe T; Yamamoto JK
J Interferon Cytokine Res; 2001 Dec; 21(12):1039-46. PubMed ID: 11798461
[TBL] [Abstract][Full Text] [Related]
40. Induction of feline immunodeficiency virus from a chronically infected feline T-lymphocyte cell line.
Tochikura TS; Naito Y; Kozutsumi Y; Hohdatsu T
Res Vet Sci; 2012 Apr; 92(2):327-32. PubMed ID: 21477828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
